160 related articles for article (PubMed ID: 18175034)
1. Alfacalcidol-stimulated focal bone formation on the cancellous surface and increased bone formation on the periosteal surface of the lumbar vertebrae of adult female rats.
Chen H; Tian X; Liu X; Setterberg RB; Li M; Jee WS
Calcif Tissue Int; 2008 Feb; 82(2):127-36. PubMed ID: 18175034
[TBL] [Abstract][Full Text] [Related]
2. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
Li M; Healy DR; Li Y; Simmons HA; Su M; Jee WS; Shen VW; Thompson DD
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):22-32. PubMed ID: 15615075
[TBL] [Abstract][Full Text] [Related]
3. Greater efficacy of alfacalcidol in the red than in the yellow marrow skeletal sites in adult female rats.
Tian XY; Liu XQ; Chen HY; Setterberg RB; Li M; Jee WS
J Musculoskelet Neuronal Interact; 2008; 8(3):257-66. PubMed ID: 18799859
[TBL] [Abstract][Full Text] [Related]
4. Alfacalcidol treatment increases bone mass from anticatabolic and anabolic effects on cancellous and cortical bone in intact female rats.
Liu XQ; Chen HY; Tian XY; Setterberg RB; Li M; Jee WS
J Bone Miner Metab; 2008; 26(5):425-35. PubMed ID: 18758900
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat.
Li CY; Jee WS; Chen JL; Mo A; Setterberg RB; Su M; Tian XY; Ling YF; Yao W
Calcif Tissue Int; 2003 Jan; 72(1):42-9. PubMed ID: 12370795
[TBL] [Abstract][Full Text] [Related]
6. Alfacalcidol restores cancellous bone in ovariectomized rats.
Li M; Healy DR; Simmons HA; Ke HZ; Thompson DD
J Musculoskelet Neuronal Interact; 2003 Mar; 3(1):39-46. PubMed ID: 15758364
[TBL] [Abstract][Full Text] [Related]
7. Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry study.
Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2007 Jun; 53(3):191-7. PubMed ID: 17874822
[TBL] [Abstract][Full Text] [Related]
8. Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats.
Tian XY; Zhang Q; Zhao R; Setterberg RB; Zeng QQ; Iturria SJ; Ma YF; Jee WS
Bone; 2008 May; 42(5):914-20. PubMed ID: 18316259
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
[TBL] [Abstract][Full Text] [Related]
10. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
[TBL] [Abstract][Full Text] [Related]
11. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
[TBL] [Abstract][Full Text] [Related]
12. Alfacalcidol increases cancellous bone in low turnover, fatty marrow sites in aged, orchidectomized rats.
Tian XY; Chen HY; Setterberg RB; Li M; Jee WS
J Musculoskelet Neuronal Interact; 2009; 9(3):138-46. PubMed ID: 19724148
[TBL] [Abstract][Full Text] [Related]
13. Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Dec; 52(6):393-401. PubMed ID: 17330501
[TBL] [Abstract][Full Text] [Related]
14. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
Iwaniec UT; Yuan D; Power RA; Wronski TJ
J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
[TBL] [Abstract][Full Text] [Related]
15. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen.
Shiraishi A; Takeda S; Masaki T; Higuchi Y; Uchiyama Y; Kubodera N; Sato K; Ikeda K; Nakamura T; Matsumoto T; Ogata E
J Bone Miner Res; 2000 Apr; 15(4):770-9. PubMed ID: 10780869
[TBL] [Abstract][Full Text] [Related]
16. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis.
Shiraishi A; Higashi S; Masaki T; Saito M; Ito M; Ikeda S; Nakamura T
Calcif Tissue Int; 2002 Jul; 71(1):69-79. PubMed ID: 12073154
[TBL] [Abstract][Full Text] [Related]
17. Alfacalcidol prevents aromatase inhibitor (Letrozole)-induced bone mineral loss in young growing female rats.
Mohamed I; Yeh JK
J Endocrinol; 2009 Aug; 202(2):317-25. PubMed ID: 19420010
[TBL] [Abstract][Full Text] [Related]
18. [Effects of alfacalcidol on osteoporosis in ovariectomized rats].
Xia W; Meng X; Xing X
Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):702-5. PubMed ID: 11798840
[TBL] [Abstract][Full Text] [Related]
19. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
Saito H; Takeda S; Amizuka N
J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
[TBL] [Abstract][Full Text] [Related]
20. Calcium supplementation does not reproduce the pharmacological efficacy of alfacalcidol for the treatment of osteoporosis in rats.
Shiraishi A; Ito M; Hayakawa N; Kubota N; Kubodera N; Ogata E
Calcif Tissue Int; 2006 Mar; 78(3):152-61. PubMed ID: 16525749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
